Skip to content

The effect of TPN combined with somatostatin in the treatment of chylous leakage after D3 radical resection for colorectal cancer: a Single-center, Prospective, Observational Clinical Trial

The effect of TPN combined with somatostatin in the treatment of chylous leakage after D3 radical resection for colorectal cancer: a Single-center, Prospective, Observational Clinical Trial

Status
Recruiting
Phases
Early Phase 1
Study type
Observational
Source
ChiCTR
Registry ID
ChiCTR2100041723
Enrollment
Unknown
Registered
2021-01-03
Start date
2021-02-01
Completion date
Unknown
Last updated
2021-03-22

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

chylous leakage

Interventions

case series:Nil

Sponsors

Union Hospital Affiliated to Fujian Medical University
Lead Sponsor

Eligibility

Sex/Gender
Male

Inclusion criteria

Inclusion criteria: 1) Preoperative ASA score was I-III; 2) D3 radical operation for colorectal cancer was performed; 3) On the first day after operation, the triglyceride level of abdominal drainage fluid was checked 6 hours after taking liquid, TG >= 1.2 mmol / L; or after taking semi liquid, the abdominal drainage tube appeared milky liquid or the drainage volume increased, TG >= 1.2 mmol / L; 4) The patients and their family members can understand the study protocol and are willing to participate in the study and sign the informed consent.

Exclusion criteria

Exclusion criteria: 1) Extraregional lymph node dissection was performed during operation; 2) Patients with intestinal obstruction, intestinal perforation, intestinal bleeding need emergency surgical resection; 3) ASA grade IV or V; 4) Patients or their families could not understand the conditions and objectives of this study.

Design outcomes

Primary

MeasureTime frame
volume of drainage;Time to resolution;Time to onset;

Countries

China

Contacts

Public ContactYu Lin

Union Hospital Affiliated to Fujian Medical University

linyu19610505@163.com+86 18559879901

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026